- Stocks Telegraph Morning
- Posts
- Sep - 13 - NH - Morning Newsletter (with survey at top and bottom)
Sep - 13 - NH - Morning Newsletter (with survey at top and bottom)
Unveiling 4 Compelling Stocks Worth Your Attention
The Newsheater daily morning newsletter is powered by Stocks Telegraph
Help us improve newsletter by taking
Good Morning!
Wednesday morning saw minimal changes in U.S. stock futures, with investors eagerly anticipating the release of the consumer price index (CPI) for additional insights into the inflation scenario.Futures linked to the Dow Jones Industrial Average experienced a slight decline of 20 points, equivalent to a 0.06% decrease. Meanwhile, S&P 500 futures displayed a marginal decrease of 0.03%, while Nasdaq 100 futures showed a slight uptick of 0.02%.Wall Street's primary focus now revolves around the impending August CPI report, scheduled for release later this morning. According to Dow Jones estimates, economists anticipate a year-over-year inflation rise of 3.6%, signaling an uptick from the previous month's reading of 3.2%. Additionally, the Core CPI, which excludes the volatile components of food and energy costs, is projected to have increased by 4.3% in August, compared to a 4.7% gain in July.
Missed NVIDIA? Don't Miss This 'Great $2 AI Moonshot' Opportunity
These fintech geniuses devised an algorithm to sniff out explosive stock moves BEFORE THEY HAPPEN.
Like the time they pinpointed NVIDIA in the early days. If you followed their advice,
a $5,000 investment could have turned into an extraordinary $38,250 in a relatively short time.
Now their research suggests we may be staring at an opportunity of this magnitude again.
And it's a tiny sub-$5 stock!
Sponsored
Today Top Movers
Avalo Therapeutics Inc. (AVTX) stock soared 73.28% to $0.214 in the pre-market trading after announcing that it has entered into an agreement to divest AVTX-800 Series.
Workhorse Group Inc. (NASDAQ: WKHS) shares are trading up 20.86% at $0.7676 at the time of writing following the receipt of IRS approval for commercial clean vehicle credit.
Rocket Pharmaceuticals Inc. (RCKT) grew over 15.57% at $17.67 in pre-market trading today after announcing pricing of public offering of common stock
Mainz Biomed N.V. (MYNZ), a Diagnostics & Research company, rose about 19.67% at $4.38 in pre-market trading Wednesday. The company announced positive topline results from its ColoFuture study.
Watch These 4 "Cheap Stocks"...
A small move in share price could go a long way!
Every investor should diversify their portfolio with true high upside stocks. And our analysts have found four stocks that offer solid growth potential.
Each of them are trading under $20 each...
Sponsored
Top Upgrades & Downgrades
BMO Capital turned bullish on AngloGold Ashanti Limited (AU), upgrading the stock to Outperform and assigning a $22 price target, representing potential upside of 24.36% from Monday's close.
CareTrust REIT Inc. (CTRE) has won the favor of RBC Capital's equity research team. The firm upgraded the shares from Sector Perform to Outperform and moved their price target to $23, suggesting 14.44% additional upside for the stock.
Bicycle Therapeutics plc (BCYC) received an upgrade from analysts at B. Riley Securities, who also set their one-year price target on the stock to $33. They changed their rating on BCYC to Buy from Neutral in a recently issued research note.
Earlier Wednesday Goldman Sachs reduced its rating on Ultrapar Participacoes S.A. (UGP) stock to Neutral from Buy and assigned the price target to $33.
Wedbush analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Apple Inc. (AAPL) has been changed to Outperform from and the new price target is set at $230.
Analysts at Wedbush downgraded Apple Inc. (AAPL)'s stock to Outperform from Tuesday.
A 10,000% Dividend?!?
This is easily the #1 Oil Play for 2023 and beyond.
Sponsored
Latest Insider Activity
Samsara Inc. (IOT) 10% Owner Andreessen Horowitz Fund IV, L announced the sale of shares taking place on Sep 08 at $30.92 for some 391,930 shares. The total came to more than $12.12 million.
Freshworks Inc. (FRSH) Director Flower Johanna sold on Sep 12 a total 12,200 shares at $22.03 on average. The insider’s sale generated proceeds of almost $0.27 million.
Charge Enterprises Inc. (CRGE) Director JACOBS GARY N declared the purchase of shares taking place on Sep 11 at $0.56 for some 5,000 shares. The transaction amount was around $2800.0.
Karyopharm Therapeutics Inc. (KPTI) Director BOHLIN GAREN G bought on Sep 12 a total 41,140 shares at $1.22 on average. The purchase cost the insider an estimated $49,985.
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Sponsored
Important Earnings
Top US earnings releases scheduled for today include Iris Energy Limited (NASDAQ:IREN). It will announce its Mar 2023 financial results. The company is expected to report earnings of -$0.26 per share from revenues of $15.13M in the three-month period.
Analysts expect Semtech Corporation (NASDAQ:SMTC) to report a net income (adjusted) of $0.02 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Jul 2023 is predicted to come in at $237.37M.
Streamline Health Solutions Inc. (STRM), due to announce earnings after the market closes today, is expected to report earnings of -$0.05 per share from revenues of $5.99M recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Wouldn’t it be great to have a personalized solution for your investing needs? We’re adding new sections to the morning newsletter with big implications. All you have to do is share your thought about the current newsletter. If you do that, we’ll do our best to take your feedback and make it a better experience for you.
We are asking for 1 minute of your time to answer 4 questions about your experience with our newsletter. We hope to use this information to create solutions that address exactly what you need!
Thank you for your continued support.
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.